Summary
In a significant market movement during May 2024, Bicycle Therapeutics was the subject of a vc funding. The transaction achieved a gross valuation of £436,427,629. Leading the round was Fairmount, RA Capital Management, Forbion, US-based healthcare-focused investor, Perceptive Advisors, Deep Track Capital, EcoR1 Capital.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Fairmount
Lead Investor / Acquirer
RA Capital Management
Lead Investor / Acquirer
Forbion
Lead Investor / Acquirer
US-based healthcare-focused investor
Lead Investor / Acquirer
Perceptive Advisors
Lead Investor / Acquirer
Deep Track Capital
Lead Investor / Acquirer
EcoR1 Capital
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in